Mural Oncology plc (MURA) NASDAQ

2.08

+0.01(+0.48%)

Updated at September 17 04:00PM

Currency In USD

Valuation

Market Cap54.6M
Enterprise Value-52.84M
P/E Ratio-0.24
PEG Ratio0.02
Price/Sales Ratio10.32
Price/Book Ratio0.61
Enterprise/Revenue-10.28
Enterprise/EBITDA0.24

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-42.14
Operating Margin-38.86

Management Effectiveness

Return On Assets-1.68
Return On Equity-1.22

Income Statement

Revenue0
Revenue/Share0.2
Gross Profit-3.51M
EBITDA-125M
Net Income-128.51M
Diluted EPS-7.58

Balance Sheet

Total Cash77.09M
Total Cash/Share4.46
Total Debt5.17M
Total Debt/Equity0.09
Current Ratio2.87
Book Value Per Share3.4

Price History

52-Week Change-37.72
52-Week High4.74
52-Week Low0.95
Moving Average 50 Days2.13
Moving Average 200 Days2.84

Statistics

Average Volume274,016
Shares Outstanding17.32M
% Held by Institutions47

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A